deltatrials
Unknown PHASE1 NCT02564328

Autologous Bone Marrow Mesenchymal Stem Cell Transplantation for Chronic Ischemic Stroke

Sponsor: Second Affiliated Hospital of Guangzhou Medical University

Conditions Stroke
Interventions Intravenous stem cell transplantation
Updated 5 times since 2017 Last updated: Sep 29, 2015 Started: Nov 30, 2014 Primary completion: Nov 30, 2016 Completion: Nov 30, 2017

This PHASE1 trial investigates Stroke and is currently ongoing. Second Affiliated Hospital of Guangzhou Medical University leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1

  4. Feb 2018 — Jan 2021 [monthly]

    Unknown Status PHASE1

    Status: Recruiting → Unknown Status

  5. Jan 2017 — Feb 2018 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Second Affiliated Hospital of Guangzhou Medical University
  • Southern Medical University, China
Data source: Southern Medical University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Guangzhou, China